BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37401516)

  • 1. Non-melanoma skin cancer event rates in a formalized clinical trial setting: considerations for clinical trial design.
    Lozar T; Kim K; Havighurst TC; Wood GS; Kolesar JM; Bailey HH
    Eur J Cancer Prev; 2024 Jan; 33(1):69-72. PubMed ID: 37401516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer.
    Bailey HH; Kim K; Verma AK; Sielaff K; Larson PO; Snow S; Lenaghan T; Viner JL; Douglas J; Dreckschmidt NE; Hamielec M; Pomplun M; Sharata HH; Puchalsky D; Berg ER; Havighurst TC; Carbone PP
    Cancer Prev Res (Phila); 2010 Jan; 3(1):35-47. PubMed ID: 20051371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase III skin cancer chemoprevention study of DFMO: long-term follow-up of skin cancer events and toxicity.
    Kreul SM; Havighurst T; Kim K; Mendonça EA; Wood GS; Snow S; Borich A; Verma A; Bailey HH
    Cancer Prev Res (Phila); 2012 Dec; 5(12):1368-74. PubMed ID: 23060038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-melanoma Skin Cancer - a Clinicopathological Study of Patients with Basal Cell Carcinoma and Squamous Cell Carcinoma.
    Bartoš V; Kullová M
    Klin Onkol; 2017; 31(1):40-45. PubMed ID: 29488777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-melanoma skin cancers between the years of 1990 and 1999 in Izmir, Turkey: demographic and clinicopathological characteristics.
    Ceylan C; Oztürk G; Alper S
    J Dermatol; 2003 Feb; 30(2):123-31. PubMed ID: 12692379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demographic and tumor characteristics of patients diagnosed with nonmelanoma skin cancer: 13-year retrospective study.
    Mistry N; Abanto Z; Bajdik C; Rivers JK
    J Cutan Med Surg; 2012; 16(1):32-8. PubMed ID: 22417993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer.
    Silverberg MJ; Leyden W; Warton EM; Quesenberry CP; Engels EA; Asgari MM
    J Natl Cancer Inst; 2013 Mar; 105(5):350-60. PubMed ID: 23291375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Health Maintenance Practices and Skin Cancer Risk as a Possible Source of Detection Bias.
    Drucker AM; Li WQ; Savitz DA; Weinstock MA; Han J; Li T; Qureshi AA; Cho E
    JAMA Dermatol; 2019 Mar; 155(3):353-357. PubMed ID: 30586131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The current burden of non-melanoma skin cancer attributable to ultraviolet radiation and related risk behaviours in Canada.
    O'Sullivan DE; Brenner DR; Villeneuve PJ; Walter SD; Demers PA; Friedenreich CM; King WD;
    Cancer Causes Control; 2021 Mar; 32(3):279-290. PubMed ID: 33394206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load.
    Asgari MM; Ray GT; Quesenberry CP; Katz KA; Silverberg MJ
    JAMA Dermatol; 2017 Sep; 153(9):892-896. PubMed ID: 28700773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group.
    Karagas MR; McDonald JA; Greenberg ER; Stukel TA; Weiss JE; Baron JA; Stevens MM
    J Natl Cancer Inst; 1996 Dec; 88(24):1848-53. PubMed ID: 8961975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
    Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
    JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial skin cancers after kidney transplantation: a retrospective single-centre study of 376 recipients.
    Kaufmann RA; Oberholzer PA; Cazzaniga S; Hunger RE
    Eur J Dermatol; 2016 Jun; 26(3):265-70. PubMed ID: 26985913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physician's health study.
    Frieling UM; Schaumberg DA; Kupper TS; Muntwyler J; Hennekens CH
    Arch Dermatol; 2000 Feb; 136(2):179-84. PubMed ID: 10677093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
    Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
    J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
    Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal cell carcinoma and squamous cell carcinoma growth rates and determinants of size in community patients.
    Kricker A; Armstrong B; Hansen V; Watson A; Singh-Khaira G; Lecathelinais C; Goumas C; Girgis A
    J Am Acad Dermatol; 2014 Mar; 70(3):456-64. PubMed ID: 24373780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis.
    Marcil I; Stern RS
    Arch Dermatol; 2000 Dec; 136(12):1524-30. PubMed ID: 11115165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence Trends of Melanoma and Nonmelanoma Skin Cancers in Jordan From 2000 to 2016.
    Almaani N; Juweid ME; Alduraidi H; Ganem N; Abu-Tayeh FA; Alrawi R; Hawwari T
    JCO Glob Oncol; 2023 Feb; 9():e2200338. PubMed ID: 36812449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of a Second Skin Cancer in a Cohort of Patients With Nonmelanoma Skin Cancer -Basal Cell Carcinoma or Squamous Cell Carcinoma-Treated With Mohs Micrographic Surgery: A National Prospective Cohort Study.
    Miñano Medrano R; López Estebaranz JL; Sanmartin-Jiménez O; Garcés JR; Rodríguez-Prieto MA; Vilarrasa-Rull E; de Eusebio-Murillo E; Escutia-Muñoz B; Flórez-Menéndez Á; Artola-Igarza JL; Alfaro-Rubio A; Redondo P; Delgado-Jiménez Y; Sánchez-Schmidt JM; Allende-Markixana I; Alonso-Pacheco ML; García-Bracamonte B; de la Cueva-Dobao P; Navarro-Tejedor R; Ciudad-Blanco C; Carnero-González L; Vázquez-Veiga H; Cano-Martínez N; Ruiz-Salas V; Sánchez-Sambucety P; Botella-Estrada R; González-Sixto B; Martorell-Calatayud A; Gil P; Morales-Gordillo V; Toll-Abelló A; Ocerin-Guerra I; Mayor-Arenal M; Suárez-Fernández R; Sainz-Gaspar L; Descalzo MA; García-Doval I;
    Actas Dermosifiliogr; 2022 May; 113(5):451-458. PubMed ID: 35431059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.